NCT00000116View on ClinicalTrials.gov

Randomized Trial of DHA for Retinitis Pigmentosa Patients Receiving Vitamin A

PHASE3CompletedINTERVENTIONAL
Enrollment

221

Participants

Timeline

Start Date

May 31, 1996

Primary Completion Date

September 30, 2002

Study Completion Date

September 30, 2002

Conditions
Retinitis Pigmentosa
Interventions
DIETARY_SUPPLEMENT

Vitamin A

15000 IU/d as retinyl palmitate

DIETARY_SUPPLEMENT

Docosahexaenoic acid

1200 mg/d

DIETARY_SUPPLEMENT

Control fatty acid

Trial Locations (1)

02114

Berman-Gund Laboratory for the Study of Retinal Degenerations, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston

All Listed Sponsors
lead

Carol Weigel DiFranco

NIH

NCT00000116 - Randomized Trial of DHA for Retinitis Pigmentosa Patients Receiving Vitamin A | Biotech Hunter | Biotech Hunter